New HPV vaccine from Merck strengthens cervical cancer protection
WASHINGTON (AP) -- The drugmaker Merck & Co. Inc. has received approval for an updated version of its Gardasil vaccine that protects against an additional five strains of the virus that causes most cases of cervical cancer.